HI HB17 | 2022 | Regular Session
Note: Carry Over of previous HB17
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 21 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: House Health, Human Services, & Homelessness Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 21 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: House Health, Human Services, & Homelessness Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a sixteen per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame.
Title
Relating To Prescription Drugs.
Sponsors
Rep. Roy Takumi [D] |
History
Date | Chamber | Action |
---|---|---|
2021-12-10 | Carried over to 2022 Regular Session. | |
2021-01-27 | House | Referred to HHH, CPC, FIN, referral sheet 1 |
2021-01-21 | House | Introduced and Pass First Reading. |
2021-01-20 | House | Pending introduction. |
Same As/Similar To
SB605 (Same As) 2021-12-10 - Carried over to 2022 Regular Session.
HB17 (Carry Over) 2021-01-27 - Referred to HHH, CPC, FIN, referral sheet 1
HB17 (Carry Over) 2021-01-27 - Referred to HHH, CPC, FIN, referral sheet 1
Subjects
Department of Commerce and Consumer Affairs
Insurance Commissioner
Notification
Prescription Drugs
Price Increases
Insurance Commissioner
Notification
Prescription Drugs
Price Increases
Hawaii State Sources
Type | Source |
---|---|
Summary | https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=HB&billnumber=17&year=2022 |
Text | https://www.capitol.hawaii.gov/session2022/bills/HB17_.HTM |